TeleLifestyleCoaching for Weight Loss

TeleLifestyleCoaching Use of Telemedicine for Weight Loss and Care of Weight Associated Illnesses

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01868763

Acronym

FitMeFit

Enrollment

180

Registered

2013-06-05

Start date

2012-08-31

Completion date

2013-03-31

Last updated

2013-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Keywords

telemedicine, coaching, lifestyle change, weight loss

Brief summary

Lifestyle changes often fail due to loss of motivation. Telemedicine and personal coaching have the potential to support lifestyle change and weight loss. Therefore, the aim of our randomized controlled trial was to examine the effect of telemedicine with and without coaching in comparison to a control group on weight loss in overweight participants.

Detailed description

In an occupational health care setting overweight employees were randomized into a three arm 12-week trial. Participants in the telemedical (TM) and telemedical coaching (TMC) group got a weighing machine and a step counter, with automatic transfer into a personalized online portal, which could be monitored from both, the participant and the study centre. The TMC group weekly got care calls from the study centre aiming to discuss measured data and to fix target agreements. The control group remained in routine care. Wilcoxon signed rank test was used to determine if differences (baseline vs. after 12 weeks) were significantly different from 0 and ANOVA test for determination of inter group differences.

Interventions

DEVICEtelemedical devices (weighing machine and step counter)

BEHAVIORALcare calls once per week for 12 weeks

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

* BMI ≥27 kg/m2

Exclusion criteria

* Hypoglycemia inducing medication * severe disease with hospital stay during the last 3 months * smoking cessation for less then 3 months * planned smoking cessation during study phase * acute infects * chronic diseases

Design outcomes

Primary

Measure	Time frame	Description
weight loss	12 weeks	Weight will be measured at baseline and after 12 weeks

Secondary

Measure	Time frame	Description
cardiometabolic risk factors	12 weeks	Body mass index \[kg/m2\], waist circumference \[cm\], blood pressure \[mmHg\], triglycerides \[mg/dl\], HbA1c \[%\], total, HDL and LDL cholesterol \[mg/dl\]

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026